News for PRA Health Sciences, Inc. (PRAH)

ICON plc , a world-leading healthcare intelligence and clinical research organization, today announced the pricing of a USD 2 billion SEC-registered bond offering, consisting of $750,000,000 5.809%...

Due to the rise in clinical trials and the introduction of new medicines, there has been a steady rise in the need for medical affairs service providers...

Earnings call: ICON reports strong Q4 and optimistic 2024 outlook

Key contract research organization market players include IQVIA, Inc., ICON plc, Abbott Laboratories, Apple, Inc., Dexcom, Inc., Fitbit, Inc., F....

ICLR | Complete Icon PLC stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

According to Market.us research, In 2022, toxicology testing led the preclinical CRO market in services, while Patient-Determined Organoid (PDO) Models...

The pharmacovigilance industry is poised for sustained growth due to the increasing complexity of drug development, stricter regulatory oversight, and the...

Imaging CRO Market (2022 – 2032) Research Report Analysis and Outlook Insights | PDF | 173 No of pages .The Imaging CRO Market research report analyses the...

Increasing number of drug development projects across the globe is a key factor driving contract research organization market revenue growth...

SECOND AMENDMENT TO CREDIT AGREEMENT This SECOND AMENDMENT to the Credit Agreement referred to below, dated as of May 2, 2023 , by and among ICON LUXEMBOURG S.À...

The global E-clinical solutions market may come across higher growth opportunities led by the growing internal competition in the pharmaceutical industry...

North America dominates the global clinical trial management software (CTMS) market. The USA is one of the most popular destinations for medical study and...

IQVIA has the potential to outperform the market in a higher inflation environment. Read why IQV stock has 28% upside potential with a price target at $282.

/PRNewswire/ -- The "Preclinical CRO Market Research Report by Services, End-user, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report...

GuruFocus Article or News written by insider and the topic is about:

GuruFocus Article or News written by insider and the topic is about:

GuruFocus Article or News written by insider and the topic is about:

GuruFocus Article or News written by insider and the topic is about:

Here's a roundup of top developments in the biotech space over the last 24 hours: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs